Illumina (ILMN) PT Raised to $305 at Guggenheim
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Price: $226.96 -4.72%
Rating Summary:
18 Buy, 20 Hold, 6 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
18 Buy, 20 Hold, 6 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Guggenheim analyst Subbu Nambi raised the price target on Illumina (NASDAQ: ILMN) to $305.00 (from $226.00) while maintaining a Buy rating.
You May Also Be Interested In
- Illumina selected to help bring precision medicine into everyday healthcare in Singapore
- Bruker (BRKR) PT Raised to $70 at Jefferies
- Procore Technologies, Inc (PCOR) PT Raised to $85 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
